Results 271 to 280 of about 6,007,439 (376)

Immuno-OncologyThe adverse event of interstitial lung disease in patients treated with antibody-drug conjugates. [PDF]

Oncologist
Fang N, Wang X, Xu Z, Zhan H, Wang Y, Zhao B, Huang H, Lin M.   +7 more
europepmc   +1 more source

Elementos clave en la implantación de sistemas de notificación de eventos adversos hospitalarios en América Latina Key elements in implementing adverse event notification systems in Latin American hospitals

, 2013
José Joaquín Mira, Malhi Cho, Dolors Cabré i Montserrat, Javier Rodríguez, Javier Santacruz   +4 more
openalex   +1 more source

A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitors.

Annals of Oncology, 2015
T. W. Chen, T. W. Chen, Albiruni R. A. Razak, Albiruni R. A. Razak, P. Bedard, P. Bedard, L. Siu, L. Siu, A. Hansen, A. Hansen   +9 more
semanticscholar   +1 more source

New Onset of Fibromyalgia After Exposure to a Combat Environment: A Longitudinal Cohort Study

Arthritis Care &Research, Accepted Article.
Objective Traumatic life events are hypothesized to be triggers for the onset of fibromyalgia. Posttraumatic stress disorder (PTSD) is a common comorbidity of fibromyalgia. However, limited prospective data are available on the development of fibromyalgia after exposure to high magnitude stress.
Jay B. Higgs, Willie J. Hale, Casey L. Straud, Jim Mintz, Stacey Young‐McCaughan, Kimberly D. Gomes, Chelsea J. Sterne, Katrina M. Lawrence‐Wolff, Alan J. Bartholomew, Kevin M. Kelly, Douglas M. Maurer, Catherine Vriend, Brett T. Litz, Douglas E. Williamson, Alan L. Peterson, for the STRONG STAR Consortium   +15 more
wiley   +1 more source

Pharmacovigilance study on neurological adverse reactions of proteasome inhibitors in the FDA adverse event reporting system. [PDF]

Front Pharmacol
Li S, Ling T, Liu Y, Li J.
europepmc   +1 more source

EP.11B.06 The Impact of Body Mass Index on Immune-Related Adverse Events and Outcomes in Patients with Lung Cancer: A Real-World Study [PDF]

Xiao Hu, Anastasia Gurinovich, Shuya Pan, Yana Salei, Jin‐Fei Lin, Angie Mae Rodday, Susan K. Parsons   +6 more
openalex   +1 more source

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐modifying Antirheumatic Drug

Arthritis Care &Research, Accepted Article.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD) Methods PrismRA incorporated 19 gene expression features and 4 clinical features to assess a patient's likelihood of ...
Fenglong Xie, Timothy Beukelman, Nicholas P McCormick, Jeffrey R Curtis   +3 more
wiley   +1 more source

Adverse events following Synflorix vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 2010-2024. [PDF]

PLoS One
Cui L, Tong N, Hou S, Yu C.
europepmc   +1 more source

Development and Preliminary In Vivo Study of 3D‐Printed Bioactive Glass Scaffolds with Trabecular Architecture

Advanced Engineering Materials, EarlyView.
This study reports the fabrication of trabecular bioactive glass scaffolds (composition “1d”: 46.1SiO2‐28.7CaO‐8.8MgO‐6.2P2O5‐5.7CaF2‐4.5Na2O wt%) through vat photopolymerization and the relevant results from mechanical testing and in vivo implantation procedures in rabbit femora, showing great promise for bone tissue engineering applications.
Dilshat Tulyaganov, Roberta Gabrieli, Avzal Akbarov, Nigora Nigmatova, Bekhzod Khabilov, Alessandro Schiavi, Martin Schwentenwein, Enrica Verné, Francesco Baino   +8 more
wiley   +1 more source

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for bimekizumab. [PDF]

Front Pharmacol
Lin Z, Yu X, Yang M, Xu J, Zhong J.
europepmc   +1 more source